featured
Use of Different Evidence-Based Cardiovascular Preventive Therapies in Patients With T2D and ASCVD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
JAMA Netw Open 2022 Feb 01;5(2)e2148030, AJ Nelson, EC O'Brien, LA Kaltenbach, JB Green, RD Lopes, CG Morse, HR Al-Khalidi, VR Aroda, MA Cavender, T Gaynor, JK Kirk, I Lingvay, ML Magwire, DK McGuire, J Pak, R Pop-Busui, CR Richardson, C Senyucel, MD Kelsey, NJ Pagidipati, CB GrangerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.